Industry Research Reports

Home > Reports > New Technology > Global Kidney-Organ Chip Market Size, Status and Forecast 2026-2032

Global Kidney-Organ Chip Market Size, Status and Forecast 2026-2032

Industry: New Technology

Published Date: 2026-08-02

Pages: 104 Pages

Report ld: 6985171

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

biaoTi Key Findings

In 2025, global production of Kidney-Organ Chip was approximately 22,599 units.

Commercial models concentrate on proximal tubule and nephrotoxicity applications

Human cells and controlled perfusion improve renal physiological relevance

Drug developers and research institutions remain the primary customer groups

Assay-ready systems reduce operational barriers for pharmaceutical laboratories

Standardization and regulatory validation determine long-term market scalability

Kidney-Organ Chip Market Size(US$)

CAGR 2026-2032

10.5%

Market Size,2032

USD 73.18

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 40.18 million

Market Forecast in 2032(Value)

US$ 73.18 million

CAGR

10.5%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Kidney-Organ Chip market was valued at US$ 35.29 million in 2025 and is anticipated to reach US$ 73.18 million by 2032, at a CAGR of 10.5% from 2026 to 2032.

A Kidney-Organ Chip, more commonly described as a Kidney Organ-on-a-Chip, is a microengineered in vitro platform designed to reproduce selected structural, mechanical, and physiological characteristics of the human kidney. The system combines human renal cells with microfluidic channels, porous membranes, extracellular matrices, controlled perfusion, and biochemical stimulation to simulate kidney functions under dynamic conditions. Depending on the model design, it may replicate the glomerular filtration barrier, proximal-tubule secretion and reabsorption, distal-tubule transport, collecting-duct function, renal vasculature, or interactions among several nephron segments. Kidney-Organ Chips are primarily used in nephrotoxicity testing, renal disease modeling, drug transport and clearance studies, pharmacokinetic research, and development of personalized therapies. The market scope includes blank microfluidic chips, cell-loaded assay-ready models, kidney organoid-on-chip products, perfusion instruments, pumps, sensors, culture media, cells, software, analytical services, customized model development, training, and maintenance. These products are laboratory research and drug-development tools rather than implantable chips, dialysis systems, or therapeutic artificial kidneys.

biaoTi Market Trends

Kidney-Organ Chip technology is progressing from basic single-channel cell-culture devices toward multicellular, vascularized, organoid-based, and interconnected renal models. Developers increasingly use human primary cells, immortalized renal cell lines, induced pluripotent stem-cell-derived cells, and adult stem-cell-derived organoids to improve physiological relevance. Dynamic perfusion and controlled shear stress support cell polarity, transporter expression, and long-term renal function. Another major trend is the development of standardized, microplate-compatible products that support automated liquid handling, high-content imaging, and medium- to high-throughput compound testing. Cell-loaded assay-ready models are becoming more important because they reduce model-establishment time and operator-dependent variability. Integrated sensors, real-time imaging, artificial-intelligence-assisted analysis, and transcriptomic or proteomic measurements are expanding functional readouts. Multi-organ configurations linking the kidney with the liver, intestine, heart, muscle, or immune system are also gaining attention for evaluating drug metabolism, systemic exposure, renal clearance, and inter-organ toxicity. These developments are gradually moving Kidney-Organ Chips from academic prototypes toward practical preclinical tools.

Market Segmentation

By Company

Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Draper Laboratory
Nortis
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Glomerular Chip
Renal Tubule Chip
Colliding Duct Chip

Segment by Application

Hospitals
Research Institutions
Universities
Others

Segment by Category

Membrane-Based Dual-Channel Type
3D Matrix-Embedded Tubular Type

Segment by Division

Primary Human Cell-Based Type
Immortalized Cell Line-Based Type
Stem Cell & Organoid-Based Type

biaoTi Market Dynamics

Drivers

The primary market driver is the need to detect drug-induced kidney injury earlier and more accurately during pharmaceutical development. Renal toxicity can result in program termination, clinical failure, restricted dosing, additional monitoring requirements, or post-market safety concerns. Conventional models may not reproduce the polarity, transporter activity, fluid flow, and epithelial-vascular interactions of the human kidney. Kidney-Organ Chips provide controlled environments for measuring drug exposure, secretion, reabsorption, permeability, biomarker release, and tissue injury over time. Growing research activity in acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited renal disorders is also expanding demand for human disease models. Additional growth factors include advances in microfluidics, stem-cell differentiation, organoid culture, three-dimensional tissue engineering, and automated imaging. Policies promoting alternatives to animal testing and pharmaceutical investment in human-relevant models further support adoption. Together, these drivers are extending Kidney-Organ Chip use from academic research to mechanistic toxicology, compound screening, translational studies, and preclinical decision support.

Restraints

Commercial expansion is restrained by the biological complexity of the kidney and the lack of universally accepted validation standards. The kidney contains multiple nephron segments, specialized epithelial cells, endothelial cells, stromal cells, immune components, and complex vascular structures responsible for filtration, secretion, reabsorption, concentration, and endocrine regulation. Most commercial models reproduce only selected functions rather than the complete organ. Human primary renal cells may exhibit donor variability and limited expansion, while immortalized or stem-cell-derived cells may not fully achieve adult tissue maturity. Microfluidic systems may experience bubbles, evaporation, contamination, inconsistent flow, material absorption, and operational complexity. Customers can also require specialized pumps, imaging equipment, analytical methods, and trained personnel. Differences in chip geometry, cell type, extracellular matrix, medium, flow rate, exposure protocol, and endpoint selection reduce comparability between platforms. Until reference compounds, performance criteria, interlaboratory studies, and regulatory pathways become more established, Kidney-Organ Chips will mainly complement rather than completely replace existing preclinical methods.

Opportunities

The strongest commercial opportunities lie in standardized and assay-ready Kidney-Organ Chip models that provide reproducible results with limited user preparation. Pharmaceutical companies require scalable platforms for nephrotoxicity screening, renal transporter analysis, biomarker assessment, compound prioritization, and mechanism-of-injury studies. Disease-specific models constructed from patient-derived cells or induced pluripotent stem cells offer opportunities in rare kidney diseases, inherited disorders, precision medicine, and individualized therapeutic development. Multi-organ systems connecting the kidney with the liver, intestine, muscle, heart, or immune system can support pharmacokinetic, metabolism, systemic toxicity, and organ-interaction studies. Suppliers can also expand through customized model development, contract testing, data analysis, regulatory consulting, software, training, and cell-and-reagent packages. Compatibility with automated laboratory workflows and standard microplate formats could accelerate adoption by large pharmaceutical organizations. China, Japan, and South Korea offer additional opportunities through expanding biopharmaceutical research, microfluidic manufacturing capabilities, organoid programs, and policies supporting alternatives to animal testing. Partnerships with contract research organizations and cell suppliers can further strengthen market access.

Challenges

The principal challenge is generating biologically meaningful and repeatable data suitable for pharmaceutical and regulatory decisions. Renal cells must maintain appropriate polarity, transporter expression, barrier integrity, metabolic activity, and responses to physiological flow throughout the required culture period. Variations in cell source, extracellular matrix, medium composition, chip material, flow conditions, and dosing procedures can materially affect results. Developers must also establish clinically relevant endpoints, including transport activity, permeability, morphology, gene expression, tissue-injury biomarkers, and recovery responses. Scaling from laboratory prototypes to standardized commercial products requires consistent microfabrication, membrane quality, surface treatment, sterilization, cell loading, packaging, storage, and shipment. Another challenge is balancing physiological complexity with throughput and operational simplicity. Highly complex vascularized or multi-organ models may offer stronger biological relevance but can be more difficult and expensive to operate. Wider adoption will require reference-compound testing, transparent performance benchmarks, standardized data formats, interlaboratory validation, and clearer regulatory acceptance of Kidney-Organ Chip evidence.

biaoTi Industry Chain Analysis

The upstream industry includes microfluidic polymers, glass substrates, porous membranes, extracellular matrices, surface coatings, renal cells, stem cells, organoids, culture media, growth factors, pumps, valves, tubing, sensors, imaging systems, and laboratory automation equipment. The quality of these inputs directly influences cell viability, flow stability, optical performance, compound absorption, and experimental reproducibility. Midstream companies design and manufacture microfluidic chips, integrate perfusion equipment, construct renal tissue models, optimize culture protocols, develop analytical software, validate biological functions, and provide assay-ready products or customized testing services. Their competitiveness depends on combining microengineering, cell biology, tissue engineering, pharmacology, and data analysis. Downstream customers include pharmaceutical and biotechnology companies, contract research organizations, universities, hospitals, government laboratories, chemical companies, cosmetics companies, and regulatory research institutions. Products reach customers through direct technical sales, specialized scientific distributors, collaborative development agreements, and contract-service models. Installation, training, model development, data interpretation, software support, and consumable supply constitute an important service layer.

biaoTi Segment Insights

By simulated renal structure, Kidney-Organ Chips can be divided into glomerulus-on-chip, proximal-tubule-on-chip, distal-tubule or collecting-duct models, and integrated nephron or multi-organ systems. Proximal-tubule models represent the most commercially developed segment because they support nephrotoxicity, secretion, reabsorption, and transporter studies. By technical architecture, the market includes membrane-based dual-channel devices, three-dimensional matrix-embedded tubular models, organoid-on-chip platforms, vascularized renal models, and bioprinted chips. By product form, products can be classified into blank chips and consumables, cell-loaded assay-ready models, perfusion instruments and complete systems, and customized testing services. By cell source, models use primary human renal cells, immortalized cell lines, induced pluripotent stem-cell-derived cells, or adult stem-cell-derived organoids. Major applications include drug-induced nephrotoxicity testing, renal disease modeling, drug transport and clearance studies, pharmacokinetic and ADME analysis, and personalized medicine. Selection depends on biological complexity, throughput, repeatability, operating difficulty, and required analytical endpoints.

biaoTi Downstream Market Opportunities

Drug-induced nephrotoxicity testing represents the leading downstream opportunity because pharmaceutical developers need to identify compounds that damage glomerular, tubular, vascular, or interstitial tissues before clinical trials. Kidney-Organ Chips can support dose-response analysis, compound ranking, transporter studies, biomarker evaluation, and investigation of injury mechanisms. Renal disease modeling offers opportunities in acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited disorders. Drug-transport and clearance models can improve understanding of secretion, reabsorption, metabolite handling, and drug-drug interactions. Multi-organ systems enable analysis of metabolites generated by the liver, substances absorbed through the intestine, and systemic toxicity involving the kidney and other tissues. Patient-derived cells and kidney organoids create longer-term opportunities in precision medicine and individualized therapy selection. Pharmaceutical companies, biotechnology firms, contract research organizations, and academic institutions are the primary customers, while chemical, cosmetics, food, and environmental-safety organizations represent additional demand for renal toxicity assessment.

biaoTi Regional Insights

North America is an important center for Kidney-Organ Chip commercialization, pharmaceutical adoption, academic research, and regulatory collaboration, supported by companies such as Emulate, Nortis, Hesperos, and Creative Biolabs. Europe has also established a strong position in organ-on-a-chip platforms, with MIMETAS, TissUse, CN Bio, Kirkstall, BEOnChip, InSphero, and Fluigent participating in kidney models, multi-organ systems, perfusion equipment, or enabling technologies. The region benefits from established pharmaceutical research, microfluidics expertise, and policies supporting non-animal testing. Asia-Pacific is developing rapidly as China, Japan, and South Korea increase investment in organoid technologies, microphysiological systems, drug-safety evaluation, and domestic laboratory equipment. Beijing Daxiang Biotech is active in organoid-chip models in China, while Nanosystems Japan and EDmicBio participate in microfluidic fabrication and three-dimensional organ-chip development. Regional expansion will depend on pharmaceutical partnerships, local cell resources, technical-service networks, regulatory validation, and the availability of trained users.

Fastest-Growing Region: Asia Pacific

XX.X
%
CAGR*
XXXX
US$ Million
XXXX
REGIONAL SHARE

By Type,2021-2032(US$ Million)

Glomerular Chip

Renal Tubule Chip

Colliding Duct Chip

By Application，2021-2032(US$ Million）

Hospitals

Research Institutions

Universities

Others

biaoTi Competitive Landscape Analysis

The competitive landscape includes dedicated Kidney-Organ Chip suppliers, broader organ-on-a-chip platform companies, perfusion-system manufacturers, microfluidic-device producers, and contract model-development providers. Emulate offers a validated Kidney-Chip model, while MIMETAS provides perfused kidney models and kidney organoid tubules through its OrganoPlate platform. Nortis is recognized for proximal-tubule chips, and TissUse develops kidney-containing multi-organ systems. CN Bio and Hesperos provide platforms capable of incorporating kidney tissues into single- or multi-organ studies. Creative Biolabs offers customized Kidney-Organ Chip development, while Kirkstall, BEOnChip, InSphero, Fluigent, and Microfluidics Innovation Center provide adaptable organ-chip, perfusion, or renal-model solutions. Asian participants include Beijing Daxiang Biotech, Nanosystems Japan, and EDmicBio. Competitive differentiation centers on renal physiological relevance, validated function, reproducibility, throughput, ease of use, cell quality, automation, data analysis, application support, and regulatory credibility rather than on microfluidic-chip production capacity alone.

biaoTi Report Scope

This report delivers a comprehensive overview of the global Kidney-Organ Chip market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Kidney-Organ Chip. The Kidney-Organ Chip market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Kidney-Organ Chip market comprehensively. Regional market sizes by Type, by Application, by Structure, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Kidney-Organ Chip manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

biaoTi Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Structure, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Kidney-Organ Chip companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYResearch's Strengths

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Kidney-Organ Chip Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Glomerular Chip

1.2.3 Renal Tubule Chip

1.2.4 Colliding Duct Chip

1.3 Market by Structure

1.3.1 Global Kidney-Organ Chip Market Size Growth Rate by Structure: 2021 vs 2025 vs 2032

1.3.2 Membrane-Based Dual-Channel Type

1.3.3 3D Matrix-Embedded Tubular Type

1.4 Market by Source

1.4.1 Global Kidney-Organ Chip Market Size Growth Rate by Source: 2021 vs 2025 vs 2032

1.4.2 Primary Human Cell-Based Type

1.4.3 Immortalized Cell Line-Based Type

1.4.4 Stem Cell & Organoid-Based Type

1.5 Market by Application

1.5.1 Global Kidney-Organ Chip Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Hospitals

1.5.3 Research Institutions

1.5.4 Universities

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Kidney-Organ Chip Market Perspective (2021–2032)

2.2 Global Kidney-Organ Chip Growth Trends by Region

2.2.1 Global Kidney-Organ Chip Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Kidney-Organ Chip Historic Market Size by Region (2021–2026)

2.2.3 Kidney-Organ Chip Forecasted Market Size by Region (2027–2032)

2.3 Kidney-Organ Chip Market Dynamics

2.3.1 Kidney-Organ Chip Industry Trends

2.3.2 Kidney-Organ Chip Market Drivers

2.3.3 Kidney-Organ Chip Market Challenges

2.3.4 Kidney-Organ Chip Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Kidney-Organ Chip Players by Revenue

3.1.1 Global Top Kidney-Organ Chip Players by Revenue (2021–2026)

3.1.2 Global Kidney-Organ Chip Revenue Market Share by Players (2021–2026)

3.2 Global Top Kidney-Organ Chip Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Kidney-Organ Chip Revenue

3.4 Global Kidney-Organ Chip Market Concentration Ratio

3.4.1 Global Kidney-Organ Chip Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Kidney-Organ Chip Revenue in 2025

3.5 Global Key Players of Kidney-Organ Chip Head Offices and Areas Served

3.6 Global Key Players of Kidney-Organ Chip, Products and Applications

3.7 Global Key Players of Kidney-Organ Chip, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Kidney-Organ Chip Breakdown Data by Type

4.1 Global Kidney-Organ Chip Historic Market Size by Type (2021–2026)

4.2 Global Kidney-Organ Chip Forecasted Market Size by Type (2027–2032)

5 Kidney-Organ Chip Breakdown Data by Application

5.1 Global Kidney-Organ Chip Historic Market Size by Application (2021–2026)

5.2 Global Kidney-Organ Chip Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Kidney-Organ Chip Market Size (2021–2032)

6.2 North America Kidney-Organ Chip Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Kidney-Organ Chip Market Size by Country (2021–2026)

6.4 North America Kidney-Organ Chip Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Kidney-Organ Chip Market Size (2021–2032)

7.2 Europe Kidney-Organ Chip Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Kidney-Organ Chip Market Size by Country (2021–2026)

7.4 Europe Kidney-Organ Chip Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Kidney-Organ Chip Market Size (2021–2032)

8.2 Asia-Pacific Kidney-Organ Chip Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Kidney-Organ Chip Market Size by Region (2021–2026)

8.4 Asia-Pacific Kidney-Organ Chip Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Kidney-Organ Chip Market Size (2021–2032)

9.2 Latin America Kidney-Organ Chip Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Kidney-Organ Chip Market Size by Country (2021–2026)

9.4 Latin America Kidney-Organ Chip Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Kidney-Organ Chip Market Size (2021–2032)

10.2 Middle East & Africa Kidney-Organ Chip Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Kidney-Organ Chip Market Size by Country (2021–2026)

10.4 Middle East & Africa Kidney-Organ Chip Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Emulate

11.1.1 Emulate Company Details

11.1.2 Emulate Business Overview

11.1.3 Emulate Kidney-Organ Chip Introduction

11.1.4 Emulate Revenue in Kidney-Organ Chip Business (2021–2026)

11.1.5 Emulate Recent Development

11.2 Mimetas

11.2.1 Mimetas Company Details

11.2.2 Mimetas Business Overview

11.2.3 Mimetas Kidney-Organ Chip Introduction

11.2.4 Mimetas Revenue in Kidney-Organ Chip Business (2021–2026)

11.2.5 Mimetas Recent Development

11.3 TissUse

11.3.1 TissUse Company Details

11.3.2 TissUse Business Overview

11.3.3 TissUse Kidney-Organ Chip Introduction

11.3.4 TissUse Revenue in Kidney-Organ Chip Business (2021–2026)

11.3.5 TissUse Recent Development

11.4 Valo Health

11.4.1 Valo Health Company Details

11.4.2 Valo Health Business Overview

11.4.3 Valo Health Kidney-Organ Chip Introduction

11.4.4 Valo Health Revenue in Kidney-Organ Chip Business (2021–2026)

11.4.5 Valo Health Recent Development

11.5 CN Bio Innovations

11.5.1 CN Bio Innovations Company Details

11.5.2 CN Bio Innovations Business Overview

11.5.3 CN Bio Innovations Kidney-Organ Chip Introduction

11.5.4 CN Bio Innovations Revenue in Kidney-Organ Chip Business (2021–2026)

11.5.5 CN Bio Innovations Recent Development

11.6 Draper Laboratory

11.6.1 Draper Laboratory Company Details

11.6.2 Draper Laboratory Business Overview

11.6.3 Draper Laboratory Kidney-Organ Chip Introduction

11.6.4 Draper Laboratory Revenue in Kidney-Organ Chip Business (2021–2026)

11.6.5 Draper Laboratory Recent Development

11.7 Nortis

11.7.1 Nortis Company Details

11.7.2 Nortis Business Overview

11.7.3 Nortis Kidney-Organ Chip Introduction

11.7.4 Nortis Revenue in Kidney-Organ Chip Business (2021–2026)

11.7.5 Nortis Recent Development

11.8 Xona Microfluidics

11.8.1 Xona Microfluidics Company Details

11.8.2 Xona Microfluidics Business Overview

11.8.3 Xona Microfluidics Kidney-Organ Chip Introduction

11.8.4 Xona Microfluidics Revenue in Kidney-Organ Chip Business (2021–2026)

11.8.5 Xona Microfluidics Recent Development

11.9 SynVivo

11.9.1 SynVivo Company Details

11.9.2 SynVivo Business Overview

11.9.3 SynVivo Kidney-Organ Chip Introduction

11.9.4 SynVivo Revenue in Kidney-Organ Chip Business (2021–2026)

11.9.5 SynVivo Recent Development

11.10 Beijing Daxiang Biotech

11.10.1 Beijing Daxiang Biotech Company Details

11.10.2 Beijing Daxiang Biotech Business Overview

11.10.3 Beijing Daxiang Biotech Kidney-Organ Chip Introduction

11.10.4 Beijing Daxiang Biotech Revenue in Kidney-Organ Chip Business (2021–2026)

11.10.5 Beijing Daxiang Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

Table of Figures

List of Tables

Table 1. Global Kidney-Organ Chip Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Glomerular Chip

Table 3. Key Players of Renal Tubule Chip

Table 4. Key Players of Colliding Duct Chip

Table 5. Global Kidney-Organ Chip Market Size Growth Rate by Structure (US$ Million): 2021 vs 2025 vs 2032

Table 6. Key Players of Membrane-Based Dual-Channel Type

Table 7. Key Players of 3D Matrix-Embedded Tubular Type

Table 8. Global Kidney-Organ Chip Market Size Growth Rate by Source (US$ Million): 2021 vs 2025 vs 2032

Table 9. Key Players of Primary Human Cell-Based Type

Table 10. Key Players of Immortalized Cell Line-Based Type

Table 11. Key Players of Stem Cell & Organoid-Based Type

Table 12. Global Kidney-Organ Chip Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 13. Global Kidney-Organ Chip Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 14. Global Kidney-Organ Chip Market Size by Region (US$ Million), 2021–2026

Table 15. Global Kidney-Organ Chip Market Share by Region (2021–2026)

Table 16. Global Kidney-Organ Chip Forecasted Market Size by Region (US$ Million), 2027–2032

Table 17. Global Kidney-Organ Chip Market Share by Region (2027–2032)

Table 18. Kidney-Organ Chip Market Trends

Table 19. Kidney-Organ Chip Market Drivers

Table 20. Kidney-Organ Chip Market Challenges

Table 21. Kidney-Organ Chip Market Restraints

Table 22. Global Kidney-Organ Chip Revenue by Players (US$ Million), 2021–2026

Table 23. Global Kidney-Organ Chip Market Share by Players (2021–2026)

Table 24. Global Top Kidney-Organ Chip Players by Tier (Tier 1, Tier 2, and Tier 3), based on Kidney-Organ Chip Revenue, 2025

Table 25. Ranking of Global Top Kidney-Organ Chip Companies by Revenue (US$ Million) in 2025

Table 26. Global 5 Largest Players Market Share by Kidney-Organ Chip Revenue (CR5 and HHI), 2021–2026

Table 27. Global Key Players of Kidney-Organ Chip, Headquarters and Area Served

Table 28. Global Key Players of Kidney-Organ Chip, Products and Applications

Table 29. Global Key Players of Kidney-Organ Chip, Date of General Availability (GA)

Table 30. Mergers and Acquisitions, Expansion Plans

Table 31. Global Kidney-Organ Chip Market Size by Type (US$ Million), 2021–2026

Table 32. Global Kidney-Organ Chip Revenue Market Share by Type (2021–2026)

Table 33. Global Kidney-Organ Chip Forecasted Market Size by Type (US$ Million), 2027–2032

Table 34. Global Kidney-Organ Chip Revenue Market Share by Type (2027–2032)

Table 35. Global Kidney-Organ Chip Market Size by Application (US$ Million), 2021–2026

Table 36. Global Kidney-Organ Chip Revenue Market Share by Application (2021–2026)

Table 37. Global Kidney-Organ Chip Forecasted Market Size by Application (US$ Million), 2027–2032

Table 38. Global Kidney-Organ Chip Revenue Market Share by Application (2027–2032)

Table 39. North America Kidney-Organ Chip Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. North America Kidney-Organ Chip Market Size by Country (US$ Million), 2021–2026

Table 41. North America Kidney-Organ Chip Market Size by Country (US$ Million), 2027–2032

Table 42. Europe Kidney-Organ Chip Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Europe Kidney-Organ Chip Market Size by Country (US$ Million), 2021–2026

Table 44. Europe Kidney-Organ Chip Market Size by Country (US$ Million), 2027–2032

Table 45. Asia-Pacific Kidney-Organ Chip Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 46. Asia-Pacific Kidney-Organ Chip Market Size by Region (US$ Million), 2021–2026

Table 47. Asia-Pacific Kidney-Organ Chip Market Size by Region (US$ Million), 2027–2032

Table 48. Latin America Kidney-Organ Chip Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Latin America Kidney-Organ Chip Market Size by Country (US$ Million), 2021–2026

Table 50. Latin America Kidney-Organ Chip Market Size by Country (US$ Million), 2027–2032

Table 51. Middle East & Africa Kidney-Organ Chip Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 52. Middle East & Africa Kidney-Organ Chip Market Size by Country (US$ Million), 2021–2026

Table 53. Middle East & Africa Kidney-Organ Chip Market Size by Country (US$ Million), 2027–2032

Table 54. Emulate Company Details

Table 55. Emulate Business Overview

Table 56. Emulate Kidney-Organ Chip Product

Table 57. Emulate Revenue in Kidney-Organ Chip Business (US$ Million), 2021–2026

Table 58. Emulate Recent Development

Table 59. Mimetas Company Details

Table 60. Mimetas Business Overview

Table 61. Mimetas Kidney-Organ Chip Product

Table 62. Mimetas Revenue in Kidney-Organ Chip Business (US$ Million), 2021–2026

Table 63. Mimetas Recent Development

Table 64. TissUse Company Details

Table 65. TissUse Business Overview

Table 66. TissUse Kidney-Organ Chip Product

Table 67. TissUse Revenue in Kidney-Organ Chip Business (US$ Million), 2021–2026

Table 68. TissUse Recent Development

Table 69. Valo Health Company Details

Table 70. Valo Health Business Overview

Table 71. Valo Health Kidney-Organ Chip Product

Table 72. Valo Health Revenue in Kidney-Organ Chip Business (US$ Million), 2021–2026

Table 73. Valo Health Recent Development

Table 74. CN Bio Innovations Company Details

Table 75. CN Bio Innovations Business Overview

Table 76. CN Bio Innovations Kidney-Organ Chip Product

Table 77. CN Bio Innovations Revenue in Kidney-Organ Chip Business (US$ Million), 2021–2026

Table 78. CN Bio Innovations Recent Development

Table 79. Draper Laboratory Company Details

Table 80. Draper Laboratory Business Overview

Table 81. Draper Laboratory Kidney-Organ Chip Product

Table 82. Draper Laboratory Revenue in Kidney-Organ Chip Business (US$ Million), 2021–2026

Table 83. Draper Laboratory Recent Development

Table 84. Nortis Company Details

Table 85. Nortis Business Overview

Table 86. Nortis Kidney-Organ Chip Product

Table 87. Nortis Revenue in Kidney-Organ Chip Business (US$ Million), 2021–2026

Table 88. Nortis Recent Development

Table 89. Xona Microfluidics Company Details

Table 90. Xona Microfluidics Business Overview

Table 91. Xona Microfluidics Kidney-Organ Chip Product

Table 92. Xona Microfluidics Revenue in Kidney-Organ Chip Business (US$ Million), 2021–2026

Table 93. Xona Microfluidics Recent Development

Table 94. SynVivo Company Details

Table 95. SynVivo Business Overview

Table 96. SynVivo Kidney-Organ Chip Product

Table 97. SynVivo Revenue in Kidney-Organ Chip Business (US$ Million), 2021–2026

Table 98. SynVivo Recent Development

Table 99. Beijing Daxiang Biotech Company Details

Table 100. Beijing Daxiang Biotech Business Overview

Table 101. Beijing Daxiang Biotech Kidney-Organ Chip Product

Table 102. Beijing Daxiang Biotech Revenue in Kidney-Organ Chip Business (US$ Million), 2021–2026

Table 103. Beijing Daxiang Biotech Recent Development

Table 104. Research Programs/Design for This Report

Table 105. Key Data Information from Secondary Sources

Table 106. Key Data Information from Primary Sources

Table 107. Authors List of This Report

List of Figures

Figure 1. Kidney-Organ Chip Picture

Figure 2. Global Kidney-Organ Chip Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Kidney-Organ Chip Market Share by Type: 2025 vs 2032

Figure 4. Glomerular Chip Features

Figure 5. Renal Tubule Chip Features

Figure 6. Colliding Duct Chip Features

Figure 7. Global Kidney-Organ Chip Market Size Comparison by Structure (US$ Million), 2021–2032

Figure 8. Membrane-Based Dual-Channel Type Features

Figure 9. 3D Matrix-Embedded Tubular Type Features

Figure 10. Global Kidney-Organ Chip Market Size Comparison by Source (US$ Million), 2021–2032

Figure 11. Primary Human Cell-Based Type Features

Figure 12. Immortalized Cell Line-Based Type Features

Figure 13. Stem Cell & Organoid-Based Type Features

Figure 14. Global Kidney-Organ Chip Market Size by Application (US$ Million), 2021–2032

Figure 15. Global Kidney-Organ Chip Market Share by Application: 2025 vs 2032

Figure 16. Hospitals Case Studies

Figure 17. Research Institutions Case Studies

Figure 18. Universities Case Studies

Figure 19. Others Case Studies

Figure 20. Kidney-Organ Chip Report Years Considered

Figure 21. Global Kidney-Organ Chip Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 22. Global Kidney-Organ Chip Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Kidney-Organ Chip Market Share by Region: 2025 vs 2032

Figure 24. Global Kidney-Organ Chip Market Share by Players in 2025

Figure 25. Global Kidney-Organ Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 26. The Top 10 and 5 Players Market Share by Kidney-Organ Chip Revenue in 2025

Figure 27. North America Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. North America Kidney-Organ Chip Market Share by Country (2021–2032)

Figure 29. United States Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Canada Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Europe Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Europe Kidney-Organ Chip Market Share by Country (2021–2032)

Figure 33. Germany Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. France Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. U.K. Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Italy Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Russia Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Ireland Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Asia-Pacific Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Asia-Pacific Kidney-Organ Chip Market Share by Region (2021–2032)

Figure 41. China Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Japan Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. South Korea Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Southeast Asia Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. India Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Australia & New Zealand Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Latin America Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Latin America Kidney-Organ Chip Market Share by Country (2021–2032)

Figure 49. Mexico Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Brazil Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Middle East & Africa Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Middle East & Africa Kidney-Organ Chip Market Share by Country (2021–2032)

Figure 53. Israel Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Saudi Arabia Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. UAE Kidney-Organ Chip Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Emulate Revenue Growth Rate in Kidney-Organ Chip Business (2021–2026)

Figure 57. Mimetas Revenue Growth Rate in Kidney-Organ Chip Business (2021–2026)

Figure 58. TissUse Revenue Growth Rate in Kidney-Organ Chip Business (2021–2026)

Figure 59. Valo Health Revenue Growth Rate in Kidney-Organ Chip Business (2021–2026)

Figure 60. CN Bio Innovations Revenue Growth Rate in Kidney-Organ Chip Business (2021–2026)

Figure 61. Draper Laboratory Revenue Growth Rate in Kidney-Organ Chip Business (2021–2026)

Figure 62. Nortis Revenue Growth Rate in Kidney-Organ Chip Business (2021–2026)

Figure 63. Xona Microfluidics Revenue Growth Rate in Kidney-Organ Chip Business (2021–2026)

Figure 64. SynVivo Revenue Growth Rate in Kidney-Organ Chip Business (2021–2026)

Figure 65. Beijing Daxiang Biotech Revenue Growth Rate in Kidney-Organ Chip Business (2021–2026)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

Related Reports

Global Kidney-Organ Chip Market Research Report 2024
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published Date: 2024-02-23
Pages: 105
USD 2900.00
(Single User License)
Global Kidney-Organ Chip Market Insights, Forecast to 2030
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published Date: 2024-04-26
Pages: 115
USD 4900.00
(Single User License)
Global Kidney-Organ Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Kidney-Organ Chip market is projected to grow from US$ 35.29 million in 2025 to US$ 73.18 million by 2032, at a CAGR of 10.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-02
Pages: 124
USD 4900.00
(Single User License)
Global Kidney-Organ Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Kidney-Organ Chip market size was US$ 35.29 million in 2025 and is forecast to reach a readjusted size of US$ 73.18 million by 2032 with a CAGR of 10.5% during the forecast period 2026-2032.
Published Date: 2026-08-02
Pages: 108
USD 4250.00
(Single User License)
Kidney-Organ Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Kidney-Organ Chip was estimated to be worth US$ 35.29 million in 2025 and is projected to reach US$ 73.18 million, growing at a CAGR of 10.5% from 2026 to 2032.
Published Date: 2026-08-02
Pages: 110
USD 3950.00
(Single User License)

Global Kidney-Organ Chip Market Research Report 2024
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published: 2024-02-23
Pages: 105
USD 2900.00 (Single User License)
Global Kidney-Organ Chip Market Insights, Forecast to 2030
A Kidney-Organ Chip, often referred to as a "kidney chip," is a microfluidic device designed to replicate the structure and function of the human kidney on a miniature scale. It is a type of organ-on-a-chip technology used in biomedical research and drug development. The Kidney-on-a-Chip model aims to mimic the physiological and biochemical processes that occur in the human kidney, providing a platform for studying kidney function, drug toxicity, and disease mechanisms.
Published: 2024-04-26
Pages: 115
USD 4900.00 (Single User License)
Global Kidney-Organ Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Kidney-Organ Chip market is projected to grow from US$ 35.29 million in 2025 to US$ 73.18 million by 2032, at a CAGR of 10.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-02
Pages: 124
USD 4900.00 (Single User License)
Global Kidney-Organ Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Kidney-Organ Chip market size was US$ 35.29 million in 2025 and is forecast to reach a readjusted size of US$ 73.18 million by 2032 with a CAGR of 10.5% during the forecast period 2026-2032.
Published: 2026-08-02
Pages: 108
USD 4250.00 (Single User License)
Kidney-Organ Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Kidney-Organ Chip was estimated to be worth US$ 35.29 million in 2025 and is projected to reach US$ 73.18 million, growing at a CAGR of 10.5% from 2026 to 2032.
Published: 2026-08-02
Pages: 110
USD 3950.00 (Single User License)